Human Granulocyte‐Macrophage Colony‐stimulating Factor Is a Growth Factor Active on Human Ovarian Cancer Cells

por Cimoli, Guido, Russo, Patrizia, Billi, Giovanna, Mariani, Gabriella Lucia, Rovini, Elisabetta, Marco, Marco
Publicado no Jpn J Cancer Res (1991)

Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials

por Dymond, Angela W., So, Karen, Martin, Paul, Huang, Yifan, Severin, Paul, Mathews, David, Lisbon, Eleanor, Mariani, Gabriella
Publicado no Eur J Clin Pharmacol (2016)

Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy S...

por Dymond, Angela W., Martin, Paul, So, Karen, Huang, Yifan, Severin, Paul, Holmes, Victoria, Mariani, Gabriella, Marbury, Thomas
Publicado no J Clin Pharmacol (2016)

Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

por Dorman, Stephanie N., Baranova, Katherina, Knoll, Joan H.M., Urquhart, Brad L., Mariani, Gabriella, Carcangiu, Maria Luisa, Rogan, Peter K.
Publicado no Mol Oncol (2015)

Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis

por Dymond, Angela W., Elks, Cathy, Martin, Paul, Carlile, David J., Mariani, Gabriella, Lovick, Susan, Huang, Yifan, Lorch, Ulrike, Brown, Helen, So, Karen
Publicado no Eur J Clin Pharmacol (2017)

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition

por Di Modica, Martina, Sfondrini, Lucia, Regondi, Viola, Varchetta, Stefania, Oliviero, Barbara, Mariani, Gabriella, Bianchi, Giulia Valeria, Generali, Daniele, Balsari, Andrea, Triulzi, Tiziana, Tagliabue, Elda
Publicado no Oncotarget (2015)

The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Tax...

por Ligorio, Francesca, Fucà, Giovanni, Zattarin, Emma, Lobefaro, Riccardo, Zambelli, Luca, Leporati, Rita, Rea, Carmen, Mariani, Gabriella, Bianchi, Giulia V., Capri, Giuseppe, de Braud, Filippo, Vernieri, Claudio
Publicado no Cancers (Basel) (2021)

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

por Vernieri, Claudio, Mennitto, Alessia, Prisciandaro, Michele, Huber, Veronica, Milano, Monica, Rinaldi, Lucia, Cona, Maria Silvia, Maggi, Claudia, Ferrari, Benvenuto, Manoukian, Siranoush, Mariani, Gabriella, Bianchi, Giulia, Capri, Giuseppe, Rivoltini, Licia, de Braud, Filippo
Publicado no Sci Rep (2018)

Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospec...

por Lobefaro, Riccardo, Zattarin, Emma, Nichetti, Federico, Prisciandaro, Michele, Ligorio, Francesca, Brambilla, Marta, Sepe, Pierangela, Corti, Francesca, Peverelli, Giorgia, Ottini, Arianna, Beninato, Teresa, Mazzeo, Laura, Rea, Carmen G., Mariani, Gabriella, de Braud, Filippo, Bianchi, Giulia V., Vernieri, Claudio, Capri, Giuseppe
Publicado no Ther Adv Med Oncol (2020)

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Cli...

por Jänne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin, Vansteenkiste, Johan
Publicado no JAMA (2017)

Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cance...

por Vernieri, Claudio, Prisciandaro, Michele, Nichetti, Federico, Lobefaro, Riccardo, Peverelli, Giorgia, Ligorio, Francesca, Zattarin, Emma, Cona, Maria Silvia, Sepe, Pierangela, Corti, Francesca, Manglaviti, Sara, Brambilla, Marta, Re, Barbara, Belfiore, Antonino, Pruneri, Giancarlo, Celio, Luigi, Mariani, Gabriella, Bianchi, Giulia Valeria, Rivoltini, Licia, Capri, Giuseppe, de Braud, Filippo
Publicado no Cancers (Basel) (2020)

A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors

por de Braud, Filippo, Machiels, Jean-Pascal H., Boggiani, Daniela, Rottey, Sylvie W.H., Duca, Matteo, Laruelle, Marie, Salvagni, Stefania, Damian, Silvia, Lapeire, Lore D.F., Tiseo, Marcello, Dermine, Alexandre, Ould-Kaci, Mahmoud, Braunger, Juergen, Rascher, Juliane, Fischer, Daniela, Hoefler, Josef, Mariani, Gabriella L., Cresta, Sara
Publicado no Cancers (Basel) (2020)

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

por Generali, Daniele, Montemurro, Filippo, Bordonaro, Roberto, Mafodda, Antonino, Romito, Sante, Michelotti, Andrea, Piovano, Pierluigi, Ionta, Maria Teresa, Bighin, Claudia, Sartori, Donata, Frassoldati, Antonio, Cazzaniga, Marina Elena, Riccardi, Ferdinando, Testore, Franco, Vici, Patrizia, Barone, Carlo Antonio, Schirone, Alessio, Piacentini, Federico, Nolè, Franco, Molino, Annamaria, Latini, Luciano, Simoncini, Edda Lucia, Roila, Fausto, Cognetti, Francesco, Nuzzo, Francesco, Foglietta, Jennifer, Minisini, Alessandro Marco, Goffredo, Francesca, Portera, Giuseppe, Ascione, Gilda, Mariani, Gabriella
Publicado no Oncologist (2017)